The main objective is to determine the clinical utility of non-invasive methods for measuring fibrosis in the initial assessment and follow-up of chronic hepatitis B in untreated adults.
In the absence of sufficient demonstration of this clinical utility, the diagnostic performances of these non-invasive methods will be defined, in comparison with liver biopsy
See also
HAS opinions and decisions
19/06/2014
Practice guidelines
07/05/2009
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
D3k9MyeAsHmB32Z3